Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > So what does exceeding expectations mean…

<< Previous

Bullboard Posts

Next >>

Comment by Gorf79on Jul 28, 2022 4:57pm

203 Views

Post# 34858255

RE:So what does exceeding expectations mean…

I'm gonna go with 47%!

If you are going to publicly state, on many occasions, that you are "exceeding expectations", a 47% mortality benefit seems about right... if not a bit light in this highly personalized environment...

I believe the Euphrates sub group demonstrated a 29% mortality benefit, so I'm benchmarking off of that for the original " expectation" of the Tigris trial.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China